Key result
The manufacturer of EpiPen clarified statements from a previous article regarding the retrieval of additional epinephrine from auto-injectors that were outdated or outside FDA-approved labeling.
A letter from the manufacturer clarifying statements about epinephrine auto-injectors in a previous article.
We read with interest the recent article by Hawkins et al, 1 entitled "Retrieval of additional epinephrine from auto-injectors." The EpiPen and EpiPen Jr auto-injectors are distributed by Mylan Specialty L.P., formerly known as Dey Pharma. The company wishes to clarify a few statements in the article that are outdated or outside of product labeling approved by the US Food and Drug Administration (FDA).
No takes yet. Share an insight, caveat, or question.
Ray A. Wolf (2014) reported a letter. Epinephrine auto-injectors was evaluated. The manufacturer of EpiPen clarified statements from a previous article regarding the retrieval of additional epinephrine from auto-injectors that were outdated or outside FDA-approved labeling.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: